REFERENCES
- Nelson LB, Maumenee IH. Ectopia lentis. Surv Ophthalmol 1982; 27: 143–160.
- Dureau P. Pathophysiology of zonular diseases. Curr Opin Ophthalmol 2008; 19: 27–30.
- Selhub J. Homocysteine metabolism. Annu Rev Nutr 1999; 19: 217–246.
- Krumdieck CL, Prince CW. Mechanisms of homocysteine toxicity on connective tissues: implications for the morbidity of aging. J Nutr 2000; 130: 365S–368S.
- Nygård O, Nordrehaug JE, Refsum H, Ueland PM, Farstad M, Vollset SE. Plasma homocysteine levels and mortality in patients with coronary artery disease. N Engl J Med 1997; 337: 230–236.
- Schofield RS, Wessel TR, Walker TC, Cleeton TS, Hill JA, Aranda JM Jr. Hyperhomocysteinemia in patients with heart failure referred for cardiac transplantation: preliminary observations. Clin Cardiol 2003; 26: 407–410.
- Van guldener C, Stehouwer CD. Homocysteine‐lowering treatment: an overview. Expert Opin Pharmacother 2001; 2: 1449–1460.
- Harrison DA, Mullaney PB, Mesfer SA, Awad AH, Dhindsa H. Management of ophthalmic complications of homocystinuria. Ophthalmology 1998; 105: 1886–1890.
- Hughes WM Jr, Rodriguez WE, Rosenberger D, Chen J, Sen U, Tyagi N, Moshal KS et al. Role of copper and homocysteine in pressure overload heart failure. Cardiovasc Toxicol 2008; 8: 137–144.